Summary
[Shenzhen Stock Exchange: Focus on monitoring of “Longjin Pharmaceutical”, “Canaan Technology“, and “Jiu’an Medical” that have recently increased abnormally. From December 27 to December 31, the Exchange took a total of 81 abnormal securities transactions Self-regulatory measures have been implemented, involving abnormal trading situations such as intraday pressures, false declarations, etc.; the recent abnormal growth of “Longjin Pharmaceutical”, “Canaan Technology” and “Jiu’an Medical” have been focused on monitoring; a total of 13 listed companies have been monitored Major issues were checked and reported to the China Securities Regulatory Commission for clues to a suspected violation of laws and regulations. (Shenzhen Stock Exchange)
1. Supervision dynamics of listed companies (December 24-December 30, 2021)
From December 24 to December 30, the firm imposed disciplinary sanctions on 2 violations involving information disclosure and standard operation violations; issued regulatory letters for 16 violations, 11 cases involving information disclosure and standard operation violations, and 5 cases Involving the trading of stocks and violations of holdings. This week, 29 letters of concern and 32 other letters were issued.
2. Market transaction supervision dynamics (December 27-December 31, 2021)
From December 27th to December 31st, our firm matched 81 casesSecuritiesSelf-regulatory measures have been adopted for abnormal trading behaviors, involving abnormal trading situations such as intraday pressure, false declarations, etc.;Longjin Pharmaceutical”“Canaan Technology”“Jiu’an Medical“To carry out key monitoring; a total of 13 major matters of listed companies were checked and reported to the China Securities Regulatory Commission for clues to a suspected violation of laws and regulations.
(Source: Shenzhen Stock Exchange)
.